 | • レポートコード：MRC2012A6461 • 出版社/出版日：GlobalInfoResearch / 2020年12月24日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、135ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品、医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、非処方医薬品の世界市場を広く調査・分析し、今後の市場展望をまとめております。非処方医薬品の種類別市場規模（ブランド医薬品、ジェネリック医薬品）、用途別市場規模（病院、クリニック、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Pfizer、Gilead Sciences、Johnson & Johnson、Roche、AbbVie、Sanofi、Amgen、Novartis、Merck & Co. (MSD)、GlaxoSmithKline (GSK)、Bayer、Takeda、AstraZeneca、Takeda、Novo Nordisk、Teva、Bristol-Myers Squibb、Boehringer Ingelheim、Allergan、Eli Lilly、 ・地域別グローバル市場分析 2015年-2020年 ・非処方医薬品の北米市場（アメリカ、カナダ、メキシコ） ・非処方医薬品のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・非処方医薬品のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・非処方医薬品の南米市場（ブラジル、アルゼンチン） ・非処方医薬品の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：ブランド医薬品、ジェネリック医薬品 ・用途別分析：病院、クリニック、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Non-prescription Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Non-prescription Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Non-prescription Drugs market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Non-prescription Drugs market has been segmented into
Brand Drugs
Generic Drug
By Application, Non-prescription Drugs has been segmented into:
Hospital
Clinic
Other
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Non-prescription Drugs market presented in the report. This section sheds light on the sales growth of different regional and country-level Non-prescription Drugs markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Non-prescription Drugs market.
The report offers in-depth assessment of the growth and other aspects of the Non-prescription Drugs market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Non-prescription Drugs Market Share Analysis
Non-prescription Drugs competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Non-prescription Drugs sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Non-prescription Drugs sales, revenue and market share for each player covered in this report.
The major players covered in Non-prescription Drugs are:
Pfizer
Gilead Sciences
Johnson & Johnson
Roche
AbbVie
Sanofi
Amgen
Novartis
Merck & Co. (MSD)
GlaxoSmithKline (GSK)
Bayer
Takeda
AstraZeneca
Takeda
Novo Nordisk
Teva
Bristol-Myers Squibb
Boehringer Ingelheim
Allergan
Eli Lilly
Among other players domestic and global, Non-prescription Drugs market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Non-prescription Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Non-prescription Drugs, with price, sales, revenue and global market share of Non-prescription Drugs in 2018 and 2019.
Chapter 3, the Non-prescription Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Non-prescription Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Non-prescription Drugs market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Non-prescription Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Non-prescription Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Non-prescription Drugs Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Brand Drugs
1.2.3 Generic Drug
1.3 Market Analysis by Application
1.3.1 Overview: Global Non-prescription Drugs Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Overview of Global Non-prescription Drugs Market
1.4.1 Global Non-prescription Drugs Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Pfizer SWOT Analysis
2.1.4 Pfizer Product and Services
2.1.5 Pfizer Non-prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Gilead Sciences
2.2.1 Gilead Sciences Details
2.2.2 Gilead Sciences Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Gilead Sciences SWOT Analysis
2.2.4 Gilead Sciences Product and Services
2.2.5 Gilead Sciences Non-prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Johnson & Johnson
2.3.1 Johnson & Johnson Details
2.3.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Johnson & Johnson SWOT Analysis
2.3.4 Johnson & Johnson Product and Services
2.3.5 Johnson & Johnson Non-prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Roche
2.4.1 Roche Details
2.4.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Roche SWOT Analysis
2.4.4 Roche Product and Services
2.4.5 Roche Non-prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 AbbVie
2.5.1 AbbVie Details
2.5.2 AbbVie Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 AbbVie SWOT Analysis
2.5.4 AbbVie Product and Services
2.5.5 AbbVie Non-prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Sanofi
2.6.1 Sanofi Details
2.6.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Sanofi SWOT Analysis
2.6.4 Sanofi Product and Services
2.6.5 Sanofi Non-prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Amgen
2.7.1 Amgen Details
2.7.2 Amgen Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Amgen SWOT Analysis
2.7.4 Amgen Product and Services
2.7.5 Amgen Non-prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Novartis
2.8.1 Novartis Details
2.8.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Novartis SWOT Analysis
2.8.4 Novartis Product and Services
2.8.5 Novartis Non-prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Merck & Co. (MSD)
2.9.1 Merck & Co. (MSD) Details
2.9.2 Merck & Co. (MSD) Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Merck & Co. (MSD) SWOT Analysis
2.9.4 Merck & Co. (MSD) Product and Services
2.9.5 Merck & Co. (MSD) Non-prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 GlaxoSmithKline (GSK)
2.10.1 GlaxoSmithKline (GSK) Details
2.10.2 GlaxoSmithKline (GSK) Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 GlaxoSmithKline (GSK) SWOT Analysis
2.10.4 GlaxoSmithKline (GSK) Product and Services
2.10.5 GlaxoSmithKline (GSK) Non-prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Bayer
2.11.1 Bayer Details
2.11.2 Bayer Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Bayer SWOT Analysis
2.11.4 Bayer Product and Services
2.11.5 Bayer Non-prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Takeda
2.12.1 Takeda Details
2.12.2 Takeda Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Takeda SWOT Analysis
2.12.4 Takeda Product and Services
2.12.5 Takeda Non-prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 AstraZeneca
2.13.1 AstraZeneca Details
2.13.2 AstraZeneca Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 AstraZeneca SWOT Analysis
2.13.4 AstraZeneca Product and Services
2.13.5 AstraZeneca Non-prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.14 Takeda
2.14.1 Takeda Details
2.14.2 Takeda Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Takeda SWOT Analysis
2.14.4 Takeda Product and Services
2.14.5 Takeda Non-prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.15 Novo Nordisk
2.15.1 Novo Nordisk Details
2.15.2 Novo Nordisk Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Novo Nordisk SWOT Analysis
2.15.4 Novo Nordisk Product and Services
2.15.5 Novo Nordisk Non-prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.16 Teva
2.16.1 Teva Details
2.16.2 Teva Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 Teva SWOT Analysis
2.16.4 Teva Product and Services
2.16.5 Teva Non-prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.17 Bristol-Myers Squibb
2.17.1 Bristol-Myers Squibb Details
2.17.2 Bristol-Myers Squibb Major Business and Total Revenue (Financial Highlights) Analysis
2.17.3 Bristol-Myers Squibb SWOT Analysis
2.17.4 Bristol-Myers Squibb Product and Services
2.17.5 Bristol-Myers Squibb Non-prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.18 Boehringer Ingelheim
2.18.1 Boehringer Ingelheim Details
2.18.2 Boehringer Ingelheim Major Business and Total Revenue (Financial Highlights) Analysis
2.18.3 Boehringer Ingelheim SWOT Analysis
2.18.4 Boehringer Ingelheim Product and Services
2.18.5 Boehringer Ingelheim Non-prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.19 Allergan
2.19.1 Allergan Details
2.19.2 Allergan Major Business and Total Revenue (Financial Highlights) Analysis
2.19.3 Allergan SWOT Analysis
2.19.4 Allergan Product and Services
2.19.5 Allergan Non-prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.20 Eli Lilly
2.20.1 Eli Lilly Details
2.20.2 Eli Lilly Major Business and Total Revenue (Financial Highlights) Analysis
2.20.3 Eli Lilly SWOT Analysis
2.20.4 Eli Lilly Product and Services
2.20.5 Eli Lilly Non-prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Non-prescription Drugs Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Non-prescription Drugs Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Non-prescription Drugs Manufacturer Market Share in 2019
3.3.2 Top 6 Non-prescription Drugs Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Non-prescription Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Non-prescription Drugs Sales and Market Share by Regions (2015-2020)
4.1.2 Global Non-prescription Drugs Revenue and Market Share by Regions (2015-2020)
4.2 North America Non-prescription Drugs Sales and Growth Rate (2015-2020)
4.3 Europe Non-prescription Drugs Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Non-prescription Drugs Sales and Growth Rate (2015-2020)
4.5 South America Non-prescription Drugs Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Non-prescription Drugs Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Non-prescription Drugs Sales, Revenue and Market Share by Country
5.1.1 North America Non-prescription Drugs Sales and Market Share by Country (2015-2020)
5.1.2 North America Non-prescription Drugs Revenue and Market Share by Country (2015-2020)
5.2 United States Non-prescription Drugs Sales and Growth Rate (2015-2020)
5.3 Canada Non-prescription Drugs Sales and Growth Rate (2015-2020)
5.4 Mexico Non-prescription Drugs Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Non-prescription Drugs Sales, Revenue and Market Share by Country
6.1.1 Europe Non-prescription Drugs Sales and Market Share by Country (2015-2020)
6.1.2 Europe Non-prescription Drugs Revenue and Market Share by Country (2015-2020)
6.2 Germany Non-prescription Drugs Sales and Growth Rate (2015-2020)
6.3 UK Non-prescription Drugs Sales and Growth Rate (2015-2020)
6.4 France Non-prescription Drugs Sales and Growth Rate (2015-2020)
6.5 Russia Non-prescription Drugs Sales and Growth Rate (2015-2020)
6.6 Italy Non-prescription Drugs Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Non-prescription Drugs Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Non-prescription Drugs Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Non-prescription Drugs Revenue and Market Share by Regions (2015-2020)
7.2 China Non-prescription Drugs Sales and Growth Rate (2015-2020)
7.3 Japan Non-prescription Drugs Sales and Growth Rate (2015-2020)
7.4 Korea Non-prescription Drugs Sales and Growth Rate (2015-2020)
7.5 India Non-prescription Drugs Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Non-prescription Drugs Sales and Growth Rate (2015-2020)
7.7 Australia Non-prescription Drugs Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Non-prescription Drugs Sales, Revenue and Market Share by Country
8.1.1 South America Non-prescription Drugs Sales and Market Share by Country (2015-2020)
8.1.2 South America Non-prescription Drugs Revenue and Market Share by Country (2015-2020)
8.2 Brazil Non-prescription Drugs Sales and Growth Rate (2015-2020)
8.3 Argentina Non-prescription Drugs Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Non-prescription Drugs Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Non-prescription Drugs Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Non-prescription Drugs Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Non-prescription Drugs Sales and Growth Rate (2015-2020)
9.3 Turkey Non-prescription Drugs Sales and Growth Rate (2015-2020)
9.4 Egypt Non-prescription Drugs Sales and Growth Rate (2015-2020)
9.5 South Africa Non-prescription Drugs Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Non-prescription Drugs Sales and Market Share by Type (2015-2020)
10.2 Global Non-prescription Drugs Revenue and Market Share by Type (2015-2020)
10.3 Global Non-prescription Drugs Price by Type (2015-2020)
11 Global Non-prescription Drugs Market Segment by Application
11.1 Global Non-prescription Drugs Sales Market Share by Application (2015-2020)
11.2 Global Non-prescription Drugs Revenue Market Share by Application (2015-2020)
11.3 Global Non-prescription Drugs Price by Application (2015-2020)
12 Market Forecast
12.1 Global Non-prescription Drugs Sales, Revenue and Growth Rate (2021-2025)
12.2 Non-prescription Drugs Market Forecast by Regions (2021-2025)
12.2.1 North America Non-prescription Drugs Market Forecast (2021-2025)
12.2.2 Europe Non-prescription Drugs Market Forecast (2021-2025)
12.2.3 Asia-Pacific Non-prescription Drugs Market Forecast (2021-2025)
12.2.4 South America Non-prescription Drugs Market Forecast (2021-2025)
12.2.5 Middle East & Africa Non-prescription Drugs Market Forecast (2021-2025)
12.3 Non-prescription Drugs Market Forecast by Type (2021-2025)
12.3.1 Global Non-prescription Drugs Sales Forecast by Type (2021-2025)
12.3.2 Global Non-prescription Drugs Market Share Forecast by Type (2021-2025)
12.4 Non-prescription Drugs Market Forecast by Application (2021-2025)
12.4.1 Global Non-prescription Drugs Sales Forecast by Application (2021-2025)
12.4.2 Global Non-prescription Drugs Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Non-prescription Drugs Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Non-prescription Drugs by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Non-prescription Drugs Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Pfizer Basic Information, Manufacturing Base and Competitors
Table 8. Pfizer Non-prescription Drugs Major Business
Table 9. Pfizer Non-prescription Drugs Total Revenue (USD Million) (2017-2018)
Table 10. Pfizer SWOT Analysis
Table 11. Pfizer Non-prescription Drugs Product and Services
Table 12. Pfizer Non-prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Gilead Sciences Basic Information, Manufacturing Base and Competitors
Table 14. Gilead Sciences Non-prescription Drugs Major Business
Table 15. Gilead Sciences Non-prescription Drugs Total Revenue (USD Million) (2017-2018)
Table 16. Gilead Sciences SWOT Analysis
Table 17. Gilead Sciences Non-prescription Drugs Product and Services
Table 18. Gilead Sciences Non-prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 20. Johnson & Johnson Non-prescription Drugs Major Business
Table 21. Johnson & Johnson Non-prescription Drugs Total Revenue (USD Million) (2017-2018)
Table 22. Johnson & Johnson SWOT Analysis
Table 23. Johnson & Johnson Non-prescription Drugs Product and Services
Table 24. Johnson & Johnson Non-prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Roche Basic Information, Manufacturing Base and Competitors
Table 26. Roche Non-prescription Drugs Major Business
Table 27. Roche Non-prescription Drugs Total Revenue (USD Million) (2017-2018)
Table 28. Roche SWOT Analysis
Table 29. Roche Non-prescription Drugs Product and Services
Table 30. Roche Non-prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. AbbVie Basic Information, Manufacturing Base and Competitors
Table 32. AbbVie Non-prescription Drugs Major Business
Table 33. AbbVie Non-prescription Drugs Total Revenue (USD Million) (2017-2018)
Table 34. AbbVie SWOT Analysis
Table 35. AbbVie Non-prescription Drugs Product and Services
Table 36. AbbVie Non-prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Sanofi Basic Information, Manufacturing Base and Competitors
Table 38. Sanofi Non-prescription Drugs Major Business
Table 39. Sanofi Non-prescription Drugs Total Revenue (USD Million) (2017-2018)
Table 40. Sanofi SWOT Analysis
Table 41. Sanofi Non-prescription Drugs Product and Services
Table 42. Sanofi Non-prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Amgen Basic Information, Manufacturing Base and Competitors
Table 44. Amgen Non-prescription Drugs Major Business
Table 45. Amgen Non-prescription Drugs Total Revenue (USD Million) (2017-2018)
Table 46. Amgen SWOT Analysis
Table 47. Amgen Non-prescription Drugs Product and Services
Table 48. Amgen Non-prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Novartis Basic Information, Manufacturing Base and Competitors
Table 50. Novartis Non-prescription Drugs Major Business
Table 51. Novartis Non-prescription Drugs Total Revenue (USD Million) (2017-2018)
Table 52. Novartis SWOT Analysis
Table 53. Novartis Non-prescription Drugs Product and Services
Table 54. Novartis Non-prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Merck & Co. (MSD) Basic Information, Manufacturing Base and Competitors
Table 56. Merck & Co. (MSD) Non-prescription Drugs Major Business
Table 57. Merck & Co. (MSD) Non-prescription Drugs Total Revenue (USD Million) (2017-2018)
Table 58. Merck & Co. (MSD) SWOT Analysis
Table 59. Merck & Co. (MSD) Non-prescription Drugs Product and Services
Table 60. Merck & Co. (MSD) Non-prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. GlaxoSmithKline (GSK) Basic Information, Manufacturing Base and Competitors
Table 62. GlaxoSmithKline (GSK) Non-prescription Drugs Major Business
Table 63. GlaxoSmithKline (GSK) Non-prescription Drugs Total Revenue (USD Million) (2017-2018)
Table 64. GlaxoSmithKline (GSK) SWOT Analysis
Table 65. GlaxoSmithKline (GSK) Non-prescription Drugs Product and Services
Table 66. GlaxoSmithKline (GSK) Non-prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Bayer Basic Information, Manufacturing Base and Competitors
Table 68. Bayer Non-prescription Drugs Major Business
Table 69. Bayer Non-prescription Drugs Total Revenue (USD Million) (2017-2018)
Table 70. Bayer SWOT Analysis
Table 71. Bayer Non-prescription Drugs Product and Services
Table 72. Bayer Non-prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. Takeda Basic Information, Manufacturing Base and Competitors
Table 74. Takeda Non-prescription Drugs Major Business
Table 75. Takeda Non-prescription Drugs Total Revenue (USD Million) (2017-2018)
Table 76. Takeda SWOT Analysis
Table 77. Takeda Non-prescription Drugs Product and Services
Table 78. Takeda Non-prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 79. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 80. AstraZeneca Non-prescription Drugs Major Business
Table 81. AstraZeneca Non-prescription Drugs Total Revenue (USD Million) (2017-2018)
Table 82. AstraZeneca SWOT Analysis
Table 83. AstraZeneca Non-prescription Drugs Product and Services
Table 84. AstraZeneca Non-prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 85. Takeda Basic Information, Manufacturing Base and Competitors
Table 86. Takeda Non-prescription Drugs Major Business
Table 87. Takeda Non-prescription Drugs Total Revenue (USD Million) (2017-2018)
Table 88. Takeda SWOT Analysis
Table 89. Takeda Non-prescription Drugs Product and Services
Table 90. Takeda Non-prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 91. Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table 92. Novo Nordisk Non-prescription Drugs Major Business
Table 93. Novo Nordisk Non-prescription Drugs Total Revenue (USD Million) (2017-2018)
Table 94. Novo Nordisk SWOT Analysis
Table 95. Novo Nordisk Non-prescription Drugs Product and Services
Table 96. Novo Nordisk Non-prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 97. Teva Basic Information, Manufacturing Base and Competitors
Table 98. Teva Non-prescription Drugs Major Business
Table 99. Teva Non-prescription Drugs Total Revenue (USD Million) (2017-2018)
Table 100. Teva SWOT Analysis
Table 101. Teva Non-prescription Drugs Product and Services
Table 102. Teva Non-prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 103. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 104. Bristol-Myers Squibb Non-prescription Drugs Major Business
Table 105. Bristol-Myers Squibb Non-prescription Drugs Total Revenue (USD Million) (2017-2018)
Table 106. Bristol-Myers Squibb SWOT Analysis
Table 107. Bristol-Myers Squibb Non-prescription Drugs Product and Services
Table 108. Bristol-Myers Squibb Non-prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 109. Boehringer Ingelheim Non-prescription Drugs Type and Application
Table 110. Boehringer Ingelheim Non-prescription Drugs Major Business
Table 111. Boehringer Ingelheim Non-prescription Drugs Total Revenue (USD Million) (2017-2018)
Table 112. Boehringer Ingelheim SWOT Analysis
Table 113. Boehringer Ingelheim Non-prescription Drugs Product and Services
Table 114. Boehringer Ingelheim Non-prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 115. Allergan Basic Information, Manufacturing Base and Competitors
Table 116. Allergan Non-prescription Drugs Major Business
Table 117. Allergan Non-prescription Drugs Total Revenue (USD Million) (2017-2018)
Table 118. Allergan SWOT Analysis
Table 119. Allergan Non-prescription Drugs Product and Services
Table 120. Allergan Non-prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 121. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 122. Eli Lilly Non-prescription Drugs Major Business
Table 123. Eli Lilly Non-prescription Drugs Total Revenue (USD Million) (2017-2018)
Table 124. Eli Lilly SWOT Analysis
Table 125. Eli Lilly Non-prescription Drugs Product and Services
Table 126. Eli Lilly Non-prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 127. Global Non-prescription Drugs Sales by Manufacturer (2018-2019) (K Units)
Table 128. Global Non-prescription Drugs Revenue by Manufacturer (2018-2019) (USD Million)
Table 129. Global Non-prescription Drugs Sales by Regions (2015-2020) (K Units)
Table 130. Global Non-prescription Drugs Sales Market Share by Regions (2015-2020)
Table 131. Global Non-prescription Drugs Revenue by Regions (2015-2020) (USD Million)
Table 132. North America Non-prescription Drugs Sales by Countries (2015-2020) (K Units)
Table 133. North America Non-prescription Drugs Sales Market Share by Countries (2015-2020)
Table 134. North America Non-prescription Drugs Revenue by Countries (2015-2020) (USD Million)
Table 135. North America Non-prescription Drugs Revenue Market Share by Countries (2015-2020)
Table 136. Europe Non-prescription Drugs Sales by Countries (2015-2020) (K Units)
Table 137. Europe Non-prescription Drugs Sales Market Share by Countries (2015-2020)
Table 138. Europe Non-prescription Drugs Revenue by Countries (2015-2020) (USD Million)
Table 139. Asia-Pacific Non-prescription Drugs Sales by Regions (2015-2020) (K Units)
Table 140. Asia-Pacific Non-prescription Drugs Sales Market Share by Regions (2015-2020)
Table 141. Asia-Pacific Non-prescription Drugs Revenue by Regions (2015-2020) (USD Million)
Table 142. South America Non-prescription Drugs Sales by Countries (2015-2020) (K Units)
Table 143. South America Non-prescription Drugs Sales Market Share by Countries (2015-2020)
Table 144. South America Non-prescription Drugs Revenue by Countries (2015-2020) (USD Million)
Table 145. South America Non-prescription Drugs Revenue Market Share by Countries (2015-2020)
Table 146. Middle East & Africa Non-prescription Drugs Sales by Countries (2015-2020) (K Units)
Table 147. Middle East & Africa Non-prescription Drugs Sales Market Share by Countries (2015-2020)
Table 148. Middle East & Africa Non-prescription Drugs Revenue by Countries (2015-2020) (USD Million)
Table 149. Middle East & Africa Non-prescription Drugs Revenue Market Share by Countries (2015-2020)
Table 150. Global Non-prescription Drugs Sales by Type (2015-2020) (K Units)
Table 151. Global Non-prescription Drugs Sales Share by Type (2015-2020)
Table 152. Global Non-prescription Drugs Revenue by Type (2015-2020) (USD Million)
Table 153. Global Non-prescription Drugs Revenue Share by Type (2015-2020)
Table 154. Global Non-prescription Drugs Sales by Application (2015-2020) (K Units)
Table 155. Global Non-prescription Drugs Sales Share by Application (2015-2020)
Table 156. Global Non-prescription Drugs Sales Forecast by Regions (2021-2025) (K Units)
Table 157. Global Non-prescription Drugs Market Share Forecast by Regions (2021-2025)
Table 158. Global Non-prescription Drugs Sales Forecast by Type (2021-2025) (K Units)
Table 159. Global Non-prescription Drugs Market Share Forecast by Type (2021-2025)
Table 160. Global Non-prescription Drugs Sales Forecast by Application (2021-2025)
Table 161. Global Non-prescription Drugs Market Share Forecast by Application (2021-2025)
Table 162. Direct Channel Pros & Cons
Table 163. Indirect Channel Pros & Cons
Table 164. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Non-prescription Drugs Picture
Figure 2. Global Sales Market Share of Non-prescription Drugs by Type in 2019
Figure 3. Brand Drugs Picture
Figure 4. Generic Drug Picture
Figure 5. Non-prescription Drugs Sales Market Share by Application in 2018
Figure 6. Hospital Picture
Figure 7. Clinic Picture
Figure 8. Other Picture
Figure 9. Global Non-prescription Drugs Market Status and Outlook (2015-2025) (USD Million)
Figure 10. United States Non-prescription Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 11. Canada Non-prescription Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Mexico Non-prescription Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Germany Non-prescription Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 14. France Non-prescription Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 15. UK Non-prescription Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Russia Non-prescription Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Italy Non-prescription Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 18. China Non-prescription Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Japan Non-prescription Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Korea Non-prescription Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 21. India Non-prescription Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Southeast Asia Non-prescription Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Australia Non-prescription Drugs Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 24. Brazil Non-prescription Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Egypt Non-prescription Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Saudi Arabia Non-prescription Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 27. South Africa Non-prescription Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Turkey Non-prescription Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Global Non-prescription Drugs Sales Market Share by Manufacturer in 2019
Figure 30. Global Non-prescription Drugs Revenue Market Share by Manufacturer in 2019
Figure 31. Top 3 Non-prescription Drugs Manufacturer (Revenue) Market Share in 2019
Figure 32. Top 6 Non-prescription Drugs Manufacturer (Revenue) Market Share in 2019
Figure 33. Key Manufacturer Market Share Trend
Figure 34. Global Non-prescription Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 35. Global Non-prescription Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 36. Global Non-prescription Drugs Revenue Market Share by Regions (2015-2020)
Figure 37. Global Non-prescription Drugs Revenue Market Share by Regions in 2018
Figure 38. North America Non-prescription Drugs Sales and Growth Rate (2015-2020)
Figure 39. Europe Non-prescription Drugs Sales and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Non-prescription Drugs Sales and Growth Rate (2015-2020)
Figure 41. South America Non-prescription Drugs Sales and Growth Rate (2015-2020)
Figure 42. Middle East & Africa Non-prescription Drugs Sales and Growth Rate (2015-2020)
Figure 43. North America Non-prescription Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 44. North America Non-prescription Drugs Sales Market Share by Countries (2015-2020)
Figure 45. North America Non-prescription Drugs Sales Market Share by Countries in 2018
Figure 46. North America Non-prescription Drugs Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 47. North America Non-prescription Drugs Revenue Market Share by Countries in 2018
Figure 48. United States Non-prescription Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 49. Canada Non-prescription Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 50. Mexico Non-prescription Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 51. Europe Non-prescription Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 52. Europe Non-prescription Drugs Revenue Market Share by Countries (2015-2020)
Figure 53. Europe Non-prescription Drugs Revenue Market Share by Countries in 2019
Figure 54. Germany Non-prescription Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 55. UK Non-prescription Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 56. France Non-prescription Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 57. Russia Non-prescription Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 58. Italy Non-prescription Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 59. Asia-Pacific Non-prescription Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 60. Asia-Pacific Non-prescription Drugs Sales Market Share by Regions 2019
Figure 61. Asia-Pacific Non-prescription Drugs Revenue Market Share by Regions 2019
Figure 62. China Non-prescription Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 63. Japan Non-prescription Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 64. Korea Non-prescription Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 65. India Non-prescription Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 66. Southeast Asia Non-prescription Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 67. South America Non-prescription Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 68. South America Non-prescription Drugs Sales Market Share by Countries in 2019
Figure 69. South America Non-prescription Drugs Revenue Market Share by Countries in 2019
Figure 70. Brazil Non-prescription Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 71. Argentina Non-prescription Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 72. Middle East and Africa Non-prescription Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 73. Middle East and Africa Non-prescription Drugs Sales Market Share by Countries in 2019
Figure 74. Middle East and Africa Non-prescription Drugs Revenue Market Share by Countries (2015-2020)
Figure 75. Middle East and Africa Non-prescription Drugs Revenue Market Share by Countries in 2019
Figure 76. Saudi Arabia Non-prescription Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 77. Egypt Non-prescription Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 78. Turkey Non-prescription Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 79. South Africa Non-prescription Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 80. Global Non-prescription Drugs Sales and Growth Rate (2021-2025) (K Units)
Figure 81. Global Non-prescription Drugs Revenue and Growth Rate (2021-2025) (USD Million)
Figure 82. North America Sales Non-prescription Drugs Market Forecast (2021-2025) (K Units)
Figure 83. Europe Sales Non-prescription Drugs Market Forecast (2021-2025) (K Units)
Figure 84. Asia-Pacific Sales Non-prescription Drugs Market Forecast (2021-2025) (K Units)
Figure 85. South America Sales Non-prescription Drugs Market Forecast (2021-2025) (K Units)
Figure 86. Middle East & Africa Sales Non-prescription Drugs Market Forecast (2021-2025) (K Units)
Figure 87. Sales Channel: Direct Channel vs Indirect Channel
高脂血症処方薬の世界市場（～2026年） Market Analysis and Insights: Global Hyperlipidemia Prescription Drugs Market The global Hyperlipidemia Prescription Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Hyperlipidemia Prescription Drugs Scope and Mar…- 処方薬の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Prescription Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Prescription Drugs market …
- 処方用皮膚科薬の世界市場（～2026年） Market Analysis and Insights: Global Prescription Dermatological Drugs Market The global Prescription Dermatological Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Prescription Dermatological Drugs Scope and Mar…
- 抗肥満処方の世界市場（～2026年） Obesity is a public health problem. Obesity is a genetic and chronic metabolic disease involving accumulation of excessive or abnormal fat in the body. It contributes to risk of chronic conditions such as cancer, hypertension, cardiovascular diseases, diabetics, obstructive sleep apnea, ventilatory …
- 処方用ペットフードの世界市場（～2026年） Market Analysis and Insights: Global Prescription Pet Foods Market The global Prescription Pet Foods market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Prescription Pet Foods Scope and Market Size Prescription Pet Foods m…